Objective: To explore the effects and mechanism of ShenQi Compound Recipe on inflammation maker of type 2 diabetes mellitus in GK rats.
Methods: Rats were ranodmly divided into Model group, Ramipril group (positive control, 1 mg/kg x d), SQCR low dosage (0.72 g/kg x d), SQCR high dosage group (2.88 g/kg x d) and Wistar control group. Each group was administrated correspondent substance respectively for 32 days. Determined C-reactive protein (CRP) by ELISA and tumour necrosis factor (TNF)-alpha by radioimmunassay. The mRNA expression of nuclear factor (NF)-kappaB p65 in aorta was determined by real time RT-PCR, and activation of it using immunohistochemistry staining.
Results: Concentrations of CRP and TNF-alpha in serum and the expression of mRNA and activation of NF-kappaB were all decreased in SQCR low and high dosage groups compared with model group (P < 0.05 or P < 0.01).
Conclusion: These results suggest that SQCR can decrease the level of inflammation maker in serum, which may be resulted from reducing the mRNA expression and activation of NF-kappaB.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Unmasking culprits: novel analysis identifies complement factors as potential therapeutic targets to mitigate inflammation during children's heart surgery.
Eur J Med Res
December 2024
Division of Cardiac Surgery, IWK Children's Heart CentreDivision of Cardiac Surgery, Dalhousie University, Halifax, Canada.
Background: Cardiopulmonary bypass (CPB) causes systemic inflammation during pediatric cardiac surgery, which can contribute to post-operative organ dysfunction and prolonged recovery. This study aims to identify key inflammatory mediators related to this clinically significant immunologic response.
Methods: Pediatric patients were enrolled in a single-arm prospective clinical study (NCT05154864) and received standard cardiac operation, CPB and subzero-balance ultrafiltration.
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.
Cell Rep Med
December 2024
Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address:
Hepatic steatosis is a central phenotype in multi-system metabolic dysfunction and is increasing in parallel with the obesity pandemic. We use a translational approach integrating clinical phenotyping and outcomes, circulating proteomics, and tissue transcriptomics to identify dynamic, functional biomarkers of hepatic steatosis. Using multi-modality imaging and broad proteomic profiling, we identify proteins implicated in the progression of hepatic steatosis that are largely encoded by genes enriched at the transcriptional level in the human liver.
View Article and Find Full Text PDFHigh neutrophil-to-lymphocyte ratio as a cost-effective marker of acute kidney injury and in-hospital mortality after cardiac surgery: a case-control study.
Ren Fail
December 2024
Department of Geriatric Nephrology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Background: Inflammation is one of the important pathophysiological characteristics of acute kidney injury (AKI) after cardiac surgery. The aim was to explore the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR), a simple and cost-effective maker of inflammatory response, and AKI after cardiac surgery. Furthermore, whether the NLR affected in-hospital mortality was also investigated.
View Article and Find Full Text PDFEffects of COVID-19 on bone fragility: a new perspective from osteoimmunological biomarkers.
Front Immunol
November 2024
IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Article Synopsis
- The study investigates how COVID-19 affects bone turnover and remodeling, an area not thoroughly examined until now, especially focusing on elderly patients facing orthopedic surgery.
- Researchers evaluated osteoimmunological biomarkers, particularly the RANKL/OPG ratio, to assess bone resorption and fragility in COVID-19-positive patients, finding significant correlations with other inflammatory markers.
- Findings suggest that using RANKL/OPG as a biomarker can enhance the clinical understanding of COVID-19's impact on bone health, particularly important for aging patients with higher risks of bone fragility during surgery.
Itching for innovation: role of aryl hydrocarbon receptor agonists as a future therapy for atopic dermatitis.
Clin Exp Dermatol
November 2024
Barts and The London Medical School, Queen Mary University of London.
Atopic dermatitis (AD) is a chronic, inflammatory skin condition which affects over 200 million people worldwide, with patients commonly presenting with dry, itchy and sore skin. The challenge in finding optimal treatment for AD stems from the heterogenous nature of the disease and its multifaceted aetiology: skin barrier dysfunction, immune system dysregulation, genetic factors, environmental factors and alterations in skin microorganisms. Traditional treatments for AD such as corticosteroids, calcineurin inhibitors and immunosuppressants have several limitations such as reoccurrence of symptoms when discontinued, lack of targeted action and risk of adverse effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!